← Open Payments lookup

WENNY LEE: Open Payments

NPI 1730604364 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,921 in 34 payments from 14 companies in 2025. Trend: 2023 $257 · 2024 $507 · 2025 $2,921

Food & beverage: $2,921
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$774
BeOne Medicines USA, Inc.4$286
AstraZeneca Pharmaceuticals LP2$260
Exelixis Inc.2$245
Astellas Pharma US Inc2$242
Janssen Biotech, Inc.2$240
GlaxoSmithKline, LLC.2$229
Ipsen Biopharmaceuticals, Inc5$206
Incyte Corporation1$126
Takeda Pharmaceuticals U.S.A., Inc.1$97

Products named: OPDIVO, TEVIMBRA, CABOMETYX, RYBREVANT, Onivyde, Jakafi, IMFINZI, Xtandi.

Industry payments across CA — which companies pay providers there.